David Johnson
Overview
David Johnson received an average of $4M in total compensation, including $125K in salary, at Enveric Biosciences between 2020 and 2021. David Johnson also received an average of $4M at Global Blood Therapeutics from 2018 to 2021, an average of $2M at Alliqua BioMedical from 2012 to 2017, and an average of $642K at Everi Holdings between 2011 and 2012.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2013
Enveric BiosciencesExecutive Chairman
Global Blood TherapeuticsChief Commercial Officer
Enveric BiosciencesExecutive Chairman
Global Blood TherapeuticsChief Commercial Officer
Global Blood TherapeuticsChief Commercial Officer
Global Blood TherapeuticsChief Commercial Officer
Alliqua BioMedicalPresident and Chief Executive Officer
Alliqua BioMedicalPresident and Chief Executive Officer
Alliqua BioMedicalPresident and Chief Executive Officer
Alliqua BioMedicalPresident and Chief Executive Officer
Source: SEC filings on September 23, 2022, April 28, 2022, May 31, 2022, April 28, 2021, May 17, 2018, May 9, 2017, April 22, 2014, and March 26, 2013.
Related executives
We found 46 more executives who work or worked at Enveric Biosciences, Global Blood Therapeutics, Alliqua BioMedical, andEveri Holdings.
Joseph Tucker
Enveric Biosciences
Chief Executive Officer
Avani Kanubaddi
Enveric Biosciences
Chief Operating Officer
Kevin Coveney
Enveric Biosciences
Chief Financial Officer
Peter Facchini
Enveric Biosciences
Chief Innovation Officer
Ted Love
Global Blood Therapeutics
Chief Executive Officer
Michael Rumbolz
Everi Holdings
Chief Executive Officer
Kim Smith-Whitley
Global Blood Therapeutics
EVP, Head of R&D
Jeffrey Farrow
Global Blood Therapeutics